Sponsored by: GE Healthcare

MRI: Page 146

GE places miniature neonatal MRI prototype in U.K.
By AuntMinnieEurope.com staff writers
GE Healthcare has installed a prototype of a miniature MRI system in the neonatal unit at the Jessop Wing Maternity Hospital in Sheffield, U.K.
January 24, 2017
2017 01 24 13 30 10 281 Baby Mri Scanner
RCR applauds results of Lancet prostate study
By AuntMinnieEurope.com staff writers
The U.K. Royal College of Radiologists (RCR) said the results of the Prostate MR Imaging Study (PROMIS), published last Thursday in the Lancet, will "lead to a paradigm shift in the way men with suspected prostate cancer are investigated."
January 23, 2017
MRI can help avoid unnecessary prostate cancer biopsies
By Wayne Forrest
By first undergoing a multiparametric MRI scan, more than 25% of men with suspected prostate cancer could avoid a needle biopsy guided by transrectal ultrasound, according to a study published online January 19 in Lancet.
January 19, 2017
2015 02 17 12 14 24 990 2015 02 17 Prostate Cad Huisman Cad Validation Bottom
Scientists use DTI-MRI to map Tasmanian tiger brain
By AuntMinnieEurope.com staff writers
Scientists have used MRI and diffusion-tensor imaging (DTI) to reconstruct the brain architecture and neural networks of the thylacine, or Tasmanian tiger, an extinct carnivorous marsupial native to Tasmania, according to research published online January 18 in PLOS One.
January 18, 2017
2017 01 19 10 50 04 882 Tasmanian Devil 20170119175100
Group calls for global research effort into gadolinium
By Wayne Forrest
Two European researchers are forging ahead with their proposal to collect clinical experiences and outcomes with gadolinium-based contrast agents (GBCAs) and store the information in a worldwide database. The ultimate goal is to further advance research into GBCA safety, as outlined in the January issue of Radiology.
January 18, 2017
2016 10 04 14 10 28 621 Gadolinium 400
Advanced MR Analytics secures large investment
By AuntMinnieEurope.com staff writers
Advanced MR Analytics (AMRA) has received an investment of approximately 8.5 million euros ($9 million U.S.) from U.S.-based Pfizer Venture Investments, Nordic VC Novo Seeds, and Industrifonden, another AMRA investor.
January 17, 2017
EMA continues investigation of gadolinium contrast agents
By AuntMinnieEurope.com staff writers
Ten months after it began its review of gadolinium contrast agents, the European Medicines Agency (EMA) has announced it is still continuing to assess the risk of gadolinium being deposited in brain tissue following MRI scans.
January 17, 2017
Siemens, Biogen team up on MRI software
By AuntMinnieEurope.com staff writers
Siemens Healthineers and biotechnology firm Biogen are collaborating to develop MRI software applications for quantifying key markers of multiple sclerosis disease activity and progression.
January 16, 2017
8th Berlin high-field MRI symposium set for June
By AuntMinnieEurope.com staff writers
The eighth International Symposium on Ultrahigh Field (UHF) MRI, to be held on 30 June in Berlin, will explore state-of-the-art clinical and preclinical UHF MRI, according to organizers.
January 15, 2017
Personal experiences in MRI: A cardiologist's perspective
By Dr. Sven Piepenburg
Dr. Sven Piepenburg is training to become a cardiologist at Würzburg University Hospital in Germany. He conducts about 800 MRI examinations on a 3-tesla scanner, mostly on patients with suspected myocardial infarction or inflammation. In this column, he writes about his experiences.
January 15, 2017
2017 01 13 12 32 07 113 2016 01 16 Sven P Thumb
Global MR market to reach $6.5B by 2022
By AuntMinnieEurope.com staff writers
The global MRI market is expected to reach $6.5 billion in revenues by 2022, with a compound annual growth rate of 3.8% from 2016 to 2022, according to a new report from Allied Market Research.
January 11, 2017
Brain tumor diagnosis, therapeutics set for growth
By AuntMinnieEurope.com staff writers
A higher incidence of various brain cancers and a growing geriatric population will propel the global market for brain tumor diagnosis and therapeutics products to reach $773.1 million in revenues by 2025, according to a new report by market research firm Grand View Research.
January 9, 2017
Previous Page
Page 146 of 266
Next Page